China Pharma Companies Look To Go Global With Affordable ARVs
This article was originally published in PharmAsia News
Executive Summary
The UN plans to increase access to antiretroviral therapy in low- and middle-income countries, providing Chinese pharma companies with a potential opportunity to manufacture generics for the global market.